Intelligence Platform
Patents
Browse 21 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12241902
Probes for detection of copper
granted patentUS 12173306
Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorde
granted patentUS 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted patentUS 11000502
Antimicrobial compositions comprising copper-hydroxypyrone complexes
granted patentUS 11000568
Means and methods for treating copper-related diseases
granted patentUS 10988778
Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorde
granted patentUS 10383940
Copper-cysteamine and methods of use
granted patentUS 10080379
Zinc and copper fortifying composition, a hydrating supplement, and process for preparing
granted patentUS 10071943
Copper catalyzed [18F]fluorination of iodonium salts
granted patentUS 10064942
Copper-cysteamine and methods of use
granted patentUS 9593131
Copper-cysteamine and methods of use
granted patentUS 8865914
Fluorescent probes for detection of copper
granted patentUS 8703987
Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile
granted patentUS 8303985
Skin treatment compositions containing copper-pigment complexes
granted patentUS 8303984
Skin treatment compositions containing copper-pigment complexes
granted patentUS 7758898
Copper lowering treatment of inflammatory and fibrotic diseases
granted patentUS 7563920
Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile
granted patentUS 7416741
Copper lowering treatment of inflammatory and fibrotic diseases
granted patentUS 7253147
Modified serum albumin with reduced affinity for nickel and copper
granted patentUS 6855340
Copper lowering treatment of inflammatory and fibrotic diseases
expired patentUS 6787636
Modified serum albumin with reduced affinity for nickel and copper
expired